FFRangio Accuracy vs. Standard FFR

CompletedOBSERVATIONAL
Enrollment

382

Participants

Timeline

Start Date

September 27, 2017

Primary Completion Date

June 8, 2018

Study Completion Date

June 8, 2018

Conditions
Coronary Artery Disease
Interventions
DEVICE

FFRangio

"FFRangio is a non-invasive image-based software device that provides physicians with a quantitative analysis of functional significance of the coronary lesion, similar to invasive FFR (Fractional Flow Reserve), and a qualitative three-dimensional model of the demonstrated coronary arteries, during routine PCI procedure. The CathWorks FFRangio software device is able to perform all required processing and calculations, based only on angiography images and hemodynamics information that are acquired during the coronary catheterization procedure.~The CathWorks FFRangioTM technology does not require any additional use of invasive devices, or any additional vasodilation treatment, as required by other known FFR techniques."

Trial Locations (9)

2100

Rigs Hospital CPH, Copenhagen

9300

OLV Ziekenhuis, Aalst

10032

Columbia University Medical Center/NewYork Presbyterian Hospital, New York

11576

St. Francis Hospital, Roslyn

49100

HaSharon Hospital, Petah Tikva

Rabin Medical Center, Petah Tikva

94305

Stanford University, Stanford

9103102

Shaare Zedek Medical Center, Jerusalem

19104-6061

University of Pennsylvania, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

CRF

UNKNOWN

lead

CathWorks Ltd.

INDUSTRY